Corvus Pharmaceuticals
CRVS
CRVS
62 hedge funds and large institutions have $159M invested in Corvus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% more funds holding
Funds holding: 47 → 62 (+15)
3.89% more ownership
Funds ownership: 44.11% → 48% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
62
Holding in Top 10
1
Calls
$6.07M
Puts
$538K
Top Buyers
| 1 | +$7.91M | |
| 2 | +$4.07M | |
| 3 | +$2.64M | |
| 4 |
Goldman Sachs
New York
|
+$1.99M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.75M |
Top Sellers
| 1 | -$8.41M | |
| 2 | -$2.12M | |
| 3 | -$1.49M | |
| 4 |
Renaissance Technologies
New York
|
-$936K |
| 5 |
Two Sigma Advisers
New York
|
-$275K |